Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ArQule, ICAgen collaborate on ion channel modulators

July 5, 1996

Gilead reports important discovery related to genetic code blocker research

July 5, 1996

Eotaxin receptor cloned: Possible implications for asthma research

July 5, 1996

Anergen, Organon to collaborate on RA treatment

July 5, 1996

ArQule obtains rights to Yale's alpha-ketoamide chemistry technology

July 5, 1996

Mitotix in-licenses p27 technology

July 5, 1996

Tripos' ChemSpace available for licensing soon

June 28, 1996

American Biogenetic Sciences obtains antibody technology from MRC

June 28, 1996

Collaboration for oral insulin formulation development

June 28, 1996

Techniclone's TNT to undergo clinical trials

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...